Physiosol is a Irrigation Irrigant in the Human Prescription Drug category. It is labeled and distributed by Icu Medical Inc.. The primary component is Sodium Chloride; Sodium Acetate Anhydrous; Sodium Gluconate; Potassium Chloride; Magnesium Chloride.
| Product ID | 0990-6141_4bcf614c-39e9-48f9-98ce-f39fb4c7140e |
| NDC | 0990-6141 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Physiosol |
| Generic Name | Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, And Magnesium Chloride |
| Dosage Form | Irrigant |
| Route of Administration | IRRIGATION |
| Marketing Start Date | 2018-07-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017637 |
| Labeler Name | ICU Medical Inc. |
| Substance Name | SODIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM GLUCONATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE |
| Active Ingredient Strength | 526 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharm Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017637 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-07-01 |
| Ingredient | Strength |
|---|---|
| SODIUM CHLORIDE | 526 mg/100mL |
| SPL SET ID: | c1dba90e-4de9-4488-9be3-64a6ac5f8d93 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-6141 | Physiosol | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE |
| 0990-6141 | Physiosol | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE |
| 0409-7670 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| 0409-7967 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| 0990-7670 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| 0990-7967 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PHYSIOSOL 77429321 3495920 Live/Registered |
ICU MEDICAL, INC. 2008-03-24 |
![]() PHYSIOSOL 72449109 0978442 Dead/Expired |
ABBOTT LABORATORIES 1973-02-16 |